Comparison of High- and Low-Dose Rivaroxaban Regimens in Elderly East Asian Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Comparison of High- and Low-Dose Rivaroxaban Regimens in Elderly East Asian Patients With Atrial Fibrillation

Published:2024 Issue:8 Volume:39 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Kim Ju Youn¹^ORCID,Kim Juwon¹^ORCID,Park Seung-Jung¹^ORCID,Park Kyoung-Min¹^ORCID,Kim June Soo¹^ORCID,Kim Sung-Hwan²^ORCID,Shim Jaemin³^ORCID,Choi Eue Keun⁴^ORCID,Kim Dae-Hyeok⁵^ORCID,Oh Il-Young⁶^ORCID,On Young Keun¹^ORCID,

Affiliation:

1. Division of Cardiology, Department of Internal Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

2. Division of Cardiology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

3. Division of Cardiology, Department of Internal Medicine, Korea University College of Medicine and Korea University Anam Hospital, Seoul, Korea.

4. Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Korea.

5. Inha University College of Medicine and Inha University Hospital, Incheon, Korea.

6. Cardiovascular Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

Funder

Bayer

Publisher

XMLink

Link

https://jkms.org/pdf/10.3346/jkms.2024.39.e72

Reference13 articles.

1. Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA 2 DS 2 -VASc score in the entire Korean population

2. Atrial Fibrillation: A Major Contributor to Stroke in the Elderly

3. Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation

4. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

5. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation